Group One Trading, L.P. Immunity Bio, Inc. Transaction History

Group One Trading, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$1.29 - $3.1 $576,298 - $1.38 Million	446,743 New	446,743 $754,000
Q1 2023 May 12, 2023	SELL	$1.35 - $4.78 $226,805 - $803,059	-168,004 Reduced 52.32%	153,089 $278,000
Q4 2022 Feb 09, 2023	SELL	$4.35 - $6.77 $259,238 - $403,458	-59,595 Reduced 15.65%	321,093 $1.63 Million
Q3 2022 Nov 09, 2022	BUY	$3.65 - $6.43 $114,741 - $202,133	31,436 Added 9.0%	380,688 $1.89 Million
Q2 2022 Aug 11, 2022	SELL	$2.68 - $6.14 $117,255 - $268,637	-43,752 Reduced 11.13%	349,252 $1.3 Million
Q1 2022 May 12, 2022	BUY	$5.05 - $7.53 $768,685 - $1.15 Million	152,215 Added 63.22%	393,004 $2.21 Million
Q4 2021 Feb 11, 2022	BUY	$5.67 - $10.18 $1.37 Million - $2.45 Million	240,789 New	240,789 $1.46 Million
Q2 2021 Aug 10, 2021	SELL	$13.41 - $22.4 $141,395 - $236,185	-10,544 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$12.83 - $42.25 $135,279 - $445,484	10,544 New	10,544 $250,000

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.